Chapter 18. Fragment-Based Drug Discovery of Kinase Inhibitors
- Rongshi Li,
- Jeffrey A. Stafford
Published Online: 28 SEP 2009
DOI: 10.1002/9780470524961.ch18
Copyright © 2009 John Wiley & Sons, Inc.
Book Title
Kinase Inhibitor Drugs
Additional Information
How to Cite
Erlanson, D. A. (2009) Fragment-Based Drug Discovery of Kinase Inhibitors, in Kinase Inhibitor Drugs (eds R. Li and J. A. Stafford), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470524961.ch18
Editor Information
Takeda San Diego, Inc., San Diego, CA 92121, USA
Publication History
- Published Online: 28 SEP 2009
- Published Print: 2 OCT 2009
ISBN Information
Print ISBN: 9780470278291
Online ISBN: 9780470524961
- Summary
- Chapter
- References
Keywords:
- fragment-based drug discovery of kinase inhibitors;
- B-Raf kinase inhibitor using fragment-based methods;
- cyclin-dependent kinase 2 (CDK2) - multiple anticancer drug target in clinics
Summary
This chapter contains sections titled:
Introduction
Historical Development
Fragment-Based Drug Discovery of Kinase Inhibitors
Related Approaches
Comparison of Fragment-Derived Molecules to Other Inhibitors
Outlook
Dedication
Acknowledgments
References